In addition, the K-M survival assay of TCGA and ICGC databases displayed that HCC sufferers with higher expression of ENO3 exhibited more prolonged OS compared with sufferers with low expression of ENO3 (Figure 1B). The gene discussed is ENO3; the disease is hepatocellular carcinoma.